倾向性评分分析比较T-3b与VATET在重症肌无力中的疗效
本研究利用倾向性评分匹配比较了扩展胸腺切除术(T-3b)与胸腔镜扩展胸腺切除术(VATET)在重症肌无力患者中的结局。共210例患者纳入分析,匹配后每组61例,VATET组术后2年药物缓解/缓解率显著高于T-3b组(68.9% vs 34.4%,p<0.001),且INCB-MG评分更低、肌肉疲劳更少。结论认为VATET是T-3b的可靠有效替代术式。
要点
- VATET组术后2年药物缓解/缓解率为68.9%,显著高于T-3b组的34.4%。
- VATET组INCB-MG评分更低(p<0.001),肌肉疲劳更少(p=0.004)。
- 在非胸腺瘤患者中亦得到相似结果。
核心结论
- VATET是重症肌无力患者胸腺切除术中T-3b的可靠有效替代术式。
研究设计与样本
- 回顾性队列研究,数据来自C. Besta神经学研究所基金会MG数据库,采用倾向性评分1:1匹配比较T-3b与VATET。
- 共210例患者纳入倾向性评分模型,匹配后数据集包含122例参与者(每组61例),所有协变量平衡良好。
主要发现
- VATET组术后2年药物缓解/缓解率为68.9%,T-3b组为34.4%(p<0.001)。
- VATET组INCB-MG评分更低(p<0.001),肌肉疲劳更少(p=0.004)。
- 仅分析非胸腺瘤MG患者时结果相似,配对统计检验亦证实上述结果。
临床怎么用
- 对于适合胸腺切除术的MG患者,VATET可作为T-3b的有效替代术式,可能提高术后2年缓解率并改善疲劳症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We performed propensity score (PS) models to compare the outcome of patients with myasthenia gravis (MG) submitted to 2 different surgical approaches: extended transsternal (T-3b) or thoracoscopic extended thymectomy (VATET). METHODS: Patients' clinical data were retrieved from the MG database of the C. Besta Neurologic Institute Foundation. In the PS analysis, a matching ratio of 1:1 of the main clinical variables was obtained for the 2 groups of patients and treatment effect was estimated by comparing their outcome. RESULTS: A total of 210 patients met the inclusion criteria, by having a complete set of clinical data, and were included in the PS model; a matched dataset of 122 participants (61 per group) showed an adequate balance of all the covariates. Our analysis demonstrated that 68.9% of patients who had thymectomy by the VATET technique reached the pharmacologic remission/remission status at 2 years from thymectomy compared to 34.4% of those operated on by the T-3b technique (p < 0.001), had a lower INCB-MG score (p < 0.001), and had less muscle fatigability (p = 0.004). Similar results were found considering only nonthymomatous patients with MG. Results were also confirmed by paired statistical tests. CONCLUSIONS: Our PS matching analysis showed that VATET is a reliable and effective surgical approach alternative to T-3b in patients with MG who are candidates for thymectomy. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with MG, VATET is more effective than T-3b thymectomy.
引用
- Brenna G, Antozzi C, Montomoli C, et al. A propensity score analysis for comparison of T-3b and VATET in myasthenia gravis. Neurology. 2017. PMID: 28592450. doi:10.1212/WNL.0000000000004082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。